Executive Summary
Human C by LG Heding·1975·Cited by 1125—A routingradioimmunoassayforhuman C-peptidein serum is described. Antibodies againsthuman C-peptidewere raised by immunizing guinea pigs withhuman
The Cedarlane radioimmunoassay (RIA) for human C-peptide stands as a crucial tool in modern endocrinology and metabolic research. This sophisticated assay allows for the precise quantification of human C-peptide, a vital biomarker reflecting endogenous insulin production. Understanding the intricacies of this RIA is paramount for researchers and clinicians aiming to accurately assess pancreatic beta-cell function, diagnose and manage diabetes, and investigate related endocrine disorders.
The Significance of Human C-Peptide Measurement
Human C-peptide is a byproduct of insulin synthesis. When proinsulin is cleaved in the pancreas to form insulin, C-peptide is released in equimolar amounts. This makes human C-peptide an excellent surrogate marker for insulin secretion from pancreatic β-cells. Unlike insulin, which is rapidly cleared from the bloodstream, C-peptide has a longer half-life, providing a more stable and reliable indicator of how much insulin the body is producing. Measuring human C-peptide levels is essential for several clinical applications, including:
* Assessing endogenous insulin production: This is particularly important in individuals with diabetes, especially Type 1 diabetes, where the pancreas may have significantly reduced or absent insulin production. Low C-peptide levels in this context indicate a deficiency in insulin secretion.
* Differentiating types of diabetes: C-peptide testing can help distinguish between Type 1 diabetes (autoimmune destruction of beta-cells, leading to low C-peptide) and Type 2 diabetes (insulin resistance with varying degrees of insulin production).
* Diagnosing insulinomas: These are tumors of the pancreas that produce excessive insulin. High C-peptide levels, along with elevated insulin, can point towards an insulinoma.
* Investigating hypoglycemia: In cases of unexplained low blood sugar, C-peptide measurements can help determine if it's due to an insulinoma or other causes.
* Monitoring pancreatic islet transplantation: Post-transplant C-peptide levels can indicate the success and function of transplanted cells.
* Supporting diagnostic interpretation beyond glucose: While glucose levels are a primary indicator of diabetes, C-peptide provides a deeper insight into the body's insulin-producing capacity.
The Cedarlane Radioimmunoassay: Principles and Methodology
The Cedarlane radioimmunoassay (RIA) for human C-peptide is a highly specific and sensitive method that utilizes the principle of competitive binding. In this assay, a known amount of radiolabeled human C-peptide competes with the human C-peptide present in the patient's sample for a limited number of binding sites on an antibody specifically designed to recognize human C-peptide.
The process typically involves:
1. Antibody Incubation: A monoclonal antibody applicable for determination of C-peptide is immobilized on a solid phase or in solution. This antibody has a high affinity for human C-peptide.
2. Sample and Tracer Addition: The patient's serum or plasma sample, containing an unknown quantity of human C-peptide, is added to the reaction mixture along with a fixed amount of radioactively labeled human C-peptide (often using 125iodine).
3. Competitive Binding: The unlabeled human C-peptide from the sample and the labeled human C-peptide compete for binding to the antibody. The higher the concentration of human C-peptide in the sample, the less labeled human C-peptide will bind to the antibody.
4. Separation and Detection: After an incubation period, the antibody-bound radiolabeled C-peptide is separated from the unbound fraction. This separation can be achieved through various methods, such as precipitation or filtration.
5. Quantification: The radioactivity of the bound fraction is then measured using a gamma counter. The amount of radioactivity is inversely proportional to the concentration of human C-peptide in the original sample. A standard curve, generated using samples with known concentrations of human C-peptide, is used to determine the C-peptide concentration in the unknown samples.
Key Features and Advantages of the Cedarlane RIA:
* High Specificity: The RIA employs antibodies specifically raised against human C-peptide, minimizing cross-reactivity with other related molecules like insulin or proinsulin. This ensures accurate measurement of human C-peptide itself.
* Exceptional Sensitivity: RIA techniques are renowned for their ability to detect very low concentrations of analytes. This is crucial for accurately measuring C-peptide levels in serum using a radioimmunoassay method, especially in individuals with very low insulin production.
* Robust and Rugged: Many RIA kits, including those for human C-peptide, have been refined over the years to improve their robustness and reliability. For instance, an improved radioimmunoassay of C-peptide has been developed to decrease the influence of various factors on the assay results.
* Established Methodology: Radioimmunoassays have a long history of use in clinical laboratories, with
Related Articles
Frequently Asked Questions
Here are the most common questions about .
Leave a Comment
Share your thoughts, feedback, or additional insights on this topic.
